COST EFFECTIVE FORMULATION DEVELOPMENT OF ROSUVASTATIN IN COMPARED TO INNOVATOR BRAND & EVALUATION OF INTERCHANGEABILITY VIA IN-VITRO BIO-EQUIVALENCE STUDY

Journal Title: World Journal of Pharmaceutical Research - Year 2017, Vol 6, Issue 11

Abstract

Generic Rosuvastatin formulation has been developed which is comparatively cost-effective as well as bio-similar in efficacy in compared with the Brand drug Crestor (Rosuvastatin). Research shows that overpriced medicines causes huge national burden and health care expenses has gone out of control. A Study results shows that millions of adults patients skip over medications to buy due to their high cost (Robin A. Cohen, Maria A. Villarroel, NCSH Researchers. 2013).[1] Research also found that patients are used to save money on drugs costs and they asked doctors for lower-cost medications, buying prescription drugs from other countries and using alternative therapies. So, high drugs costs problems can be handled by development of cost-effective generic drugs with same therapeutic efficacy or bio-similar to brand name drugs. According to US. FDA - a generic medicine give the identical clinical benefit and works in the same way like other brand-name version drugs. This standard applies to all FDA-approved generic medicines in safety, dosage form, strength, quality, route of administration, and intended use”(US FDA 2017).[2] So, with the main focusing of cost-defective formulation development, we have tried to evaluate the overall quality of developed drugs from the points of - dosage form, therapeutic efficacy, strength, safety, route of administration, performance quality, characteristics and intended use. We have conducted an In-Vitro Bio-Equivalence Study to establish the bio-similarity of Generic Rosuvastatin and we have achieved similar results like Brand name Rosuvastatin- Crestor. New developed Generic Rosuvastatin tablets found therapeutically bio-equivalent as the Brand name innovator and more cost-effective than brand drug.

Authors and Affiliations

Farzana Hasin

Keywords

Related Articles

PRE-ECLAMPSIA IN TAIF REGION, SAUDI ARABIA

A retrospective study was conducted over 12 months period (1/1/2017 till 31/12/2017) On 22,000 maternities delivered in the main three ministries of health (MOH) hospitals in mekkah region (king abdul aziz specialist hos...

NASAL DRUG DELIVERY SYSTEM: A ROUTE FOR BRAINE TARGETTING

Present review highlights the potential of nasal mucosa as an administration route for targeting the central nervous system, the brain. Targeted drug delivery seeks to concentrate the medication in the tissues of interes...

SYNTHESIS AND CHARACTERIZATION OF GOLD AS NANOPARTICLE BY GREEN METHODS

In this paper, we synthesized the spherical gold nanoparticles (AuNPs) of 70 nm size, using HAUCL solution and the aqueous extract of Fenugreek plant seeds, which can act as a reducing, stabilizing and capping agent, at...

A CRITICAL ANALYSIS OF AYURVEDIC HERBS USED IN VAATSHLESHAMIK JWARA W.S.R. TO SWINE FLU

Major concept of aurveda is prevention and cure of a disease by natural ways. In Ayurveda it is said that pragyapradh is the main cause of janpadodhwans (epidemic/pandemic disease). In August 2010, the World Health Organ...

DETERMINING THE ANTIMICROBIAL ACTIVITY OF THE EXTRACTS OF GINGER AND TURMERIC INCLUDING ITS AQUEOUS, ETHANOLIC AND n-HEXANE EXTRACTS AND DETERMINING ITS LEVEL OF EFFICACY COMPARED TO A STANDARD ANTIMICROBIAL DRUG

Ginger and Turmeric are not just used for culinary but exhibits good therapeutic qualities used for the prevention and treatment of various ailments. Chemical analysis has proved that each consists of over 400 different...

Download PDF file
  • EP ID EP674247
  • DOI -
  • Views 264
  • Downloads 0

How To Cite

Farzana Hasin (2017). COST EFFECTIVE FORMULATION DEVELOPMENT OF ROSUVASTATIN IN COMPARED TO INNOVATOR BRAND & EVALUATION OF INTERCHANGEABILITY VIA IN-VITRO BIO-EQUIVALENCE STUDY. World Journal of Pharmaceutical Research, 6(11), 72-86. https://europub.co.uk./articles/-A-674247